Eastern Bank’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$266K Sell
506
-90
-15% -$50.5K ﹤0.01% 363
2026
Q1
$335K Sell
596
-8
-1% -$5.13K 0.01% 316
2025
Q4
$409K Buy
604
+535
+775% +$364K 0.01% 277
2025
Q3
$44.1K Hold
69
﹤0.01% 587
2025
Q2
$37K Sell
69
-5
-7% -$2.39K ﹤0.01% 591
2025
Q1
$31.1K Sell
74
-105
-59% -$45.6K ﹤0.01% 618
2024
Q4
$74K Hold
179
﹤0.01% 509
2024
Q3
$90.4K Buy
+179
New +$87K ﹤0.01% 476
2022
Q3
Sell
-1,800
Closed -$631K 197
2022
Q2
$631K Hold
1,800
0.03% 145
2022
Q1
$985K Sell
1,800
-50
-3% -$26.3K 0.05% 127
2021
Q4
$1.22M Sell
1,850
-50
-3% -$31.4K 0.05% 126
2021
Q3
$1.18M Sell
1,900
-110
-5% -$73.9K 0.06% 120
2021
Q2
$1.27M Hold
2,010
0.06% 122
2021
Q1
$984K Hold
2,010
0.05% 127
2020
Q4
$1M Buy
+2,010
New +$899K 0.06% 118

Other funds holding IDXX

Eastern Bank's IDXX Position: Q2 2026 in Review

Eastern Bank reduced its Idexx Laboratories (IDXX) stake by 15% in Q2 2026, selling an estimated $50.5K and leaving 506 shares worth $266K. The position accounts for ﹤0.01% of the portfolio, ranked #363.

Eastern Bank first reported a position in IDXX in Q4 2020 and has held it in 15 quarters since. The position peaked at $1.27M in Q2 2021. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Eastern Bank held 506 shares of Idexx Laboratories worth $266K as of Q2 2026.
  • Eastern Bank sold 90 Idexx Laboratories shares in Q2 2026, an estimated $50.5K.
  • Idexx Laboratories made up ﹤0.01% of Eastern Bank's portfolio in Q2 2026, its #363 holding.
  • Eastern Bank first reported a position in Idexx Laboratories in Q4 2020 and has held it in 15 quarters since.
  • Eastern Bank's Idexx Laboratories position peaked at $1.27M in Q2 2021.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Eastern Bank's 13F filing for Q2 2026, filed 1 Jul 2026.